Zydus Lifesciences announces execution of undertakings to tender over 22 lakh Amplitude Surgical shares
Ahmedabad: Zydus Lifesciences Limited has announced the execution of undertakings from 7 shareholders to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company’s capital and voting rights by them.
Read also: Zydus Lifesciences venture capital arm invests in Feldan Therapeutics
Medical Dialogues team had earlier reported that the Company had entered into exclusive negotiations to purchase from PAI Partners and Amplitude Surgical's management, as well as two minority shareholders, 85.6% of the share capital of Amplitude Surgical, at a price of €6.25 per Amplitude Surgical share (the “Block Acquisition”).
Read also: Zydus Lifesciences to acquire Amplitude Surgical for Rs 2,447 crore
Zydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.